Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cortisol Replacement in Children with Sepsis Study
NCT01047670Phase 3Unknown
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in septic shock comparing Hydrocortisone with Placebo (2 arms). Primary endpoint: Number of days free of vasoactive support at 7 days. Status: unknown.
02
Drugs
hydrocortisone
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT01047670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01047670.